Nutex Health (NUTX)
(Delayed Data from NSDQ)
$96.11 USD
+3.15 (3.39%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $96.30 +0.19 (0.20%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NUTX 96.11 +3.15(3.39%)
Will NUTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NUTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NUTX
NUTX Crossed Above 50 Day Moving Average on September 20
20 Day Moving Average Support appears for NUTX after 3.31% move
NUTX Crossed Above 20 Day Moving Average on September 17
Fell Below 20 Day Moving Average appears for NUTX after 7.92% move
Fell Below 50 Day Moving Average appears for NUTX after 1.57% move